Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients

NCT01264874 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT01264874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01264874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients
Lead sponsor
European Institute of Oncology
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2010
Completion date
July 31, 2017
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma